Genus announces that Professor Ian Charles has informed the Company of his intention to step down and retire from the Genus Board, effective from 31 May 2021. Professor Charles has served as a Non-Executive Director and advisor to the Genus Portfolio Steering Committee ('GPSC') for over three years. Genus also announced the appointment of Professor Jason Chinto the Board as a Non-Executive Director, with effect from 1 April 2021. Professor Chin will become the Board's advisor to the GPSC upon Professor Charles' retirement. Professor Chin is the Head of the Centre for Chemical and Synthetic Biology at the Medical Research Council Laboratory for Molecular Biology in Cambridge, where he works across disciplines to develop and apply methods for reprogramming the genetic code of living organisms.